Literature DB >> 15332427

Dying and defibrillation: a shocking experience.

Vinod Nambisan1, David Chao.   

Abstract

Palliative Care physicians are frequently involved in the care of patients with significant comorbidity and often have to take coexisting conditions into account when treating patients. An example of an area in which this is particularly relevant and will undoubtedly increase is presented with the case report of a patient with terminal metastatic lung carcinoma and an Implantable Cardioverter Defibrillator (ICD) in place. The role of the ICD in preventing the patient from dying comfortably is discussed, as are means of deactivating the device. We conclude that patients with ICDs and terminal disease should have the issue of deactivation addressed at the earliest possible opportunity as practical difficulties may arise in the emergency setting, especially in the nonhospital environment.

Entities:  

Mesh:

Year:  2004        PMID: 15332427     DOI: 10.1191/0269216304pm907cr

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

Review 1.  [Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Authors:  K-H Ladwig; N F Ischinger; J Ronel; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-09

2.  [Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)].

Authors:  K-H Ladwig; J Ronel; J Baumert; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

3.  The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.

Authors:  Ruth England; Tim England; John Coggon
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

Review 4.  The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Authors:  Jörg Carlsson; Norbert W Paul; Matthias Dann; Jörg Neuzner; Dietrich Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2012-08-20       Impact factor: 5.594

5.  Patient preferences for deactivation of implantable cardioverter-defibrillators.

Authors:  John A Dodson; Terri R Fried; Peter H Van Ness; Nathan E Goldstein; Rachel Lampert
Journal:  JAMA Intern Med       Date:  2013-03-11       Impact factor: 21.873

Review 6.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.